ArticleInternal medicine (Tokyo, Japan)2025

Grade 3 Pancreatic Neuroendocrine Tumor Refractory to Chemotherapy Successfully Treated with Peptide Receptor Radionuclide Therapy Leading to Conversion Surgery.

Kotaro Sakaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.